Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4672 | 1672 | 33.9 | 59% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BONE LEAD | Author keyword | 38 | 56% | 3% | 46 |
2 | ALAD POLYMORPHISM | Author keyword | 21 | 90% | 1% | 9 |
3 | LEAD NEPHROPATHY | Author keyword | 15 | 82% | 1% | 9 |
4 | BLOOD LEAD | Author keyword | 15 | 19% | 4% | 69 |
5 | K X RAY FLUORESCENCE | Author keyword | 11 | 69% | 1% | 9 |
6 | DELTA AMINOLEVULINIC ACID DEHYDRATASE | Author keyword | 10 | 30% | 2% | 29 |
7 | BODY LEAD BURDEN | Author keyword | 9 | 83% | 0% | 5 |
8 | LEAD BINDING PROTEINS | Author keyword | 9 | 83% | 0% | 5 |
9 | PLASMA LEAD | Author keyword | 8 | 70% | 0% | 7 |
10 | ALAD | Author keyword | 8 | 36% | 1% | 17 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BONE LEAD | 38 | 56% | 3% | 46 | Search BONE+LEAD | Search BONE+LEAD |
2 | ALAD POLYMORPHISM | 21 | 90% | 1% | 9 | Search ALAD+POLYMORPHISM | Search ALAD+POLYMORPHISM |
3 | LEAD NEPHROPATHY | 15 | 82% | 1% | 9 | Search LEAD+NEPHROPATHY | Search LEAD+NEPHROPATHY |
4 | BLOOD LEAD | 15 | 19% | 4% | 69 | Search BLOOD+LEAD | Search BLOOD+LEAD |
5 | K X RAY FLUORESCENCE | 11 | 69% | 1% | 9 | Search K+X+RAY+FLUORESCENCE | Search K+X+RAY+FLUORESCENCE |
6 | DELTA AMINOLEVULINIC ACID DEHYDRATASE | 10 | 30% | 2% | 29 | Search DELTA+AMINOLEVULINIC+ACID+DEHYDRATASE | Search DELTA+AMINOLEVULINIC+ACID+DEHYDRATASE |
7 | BODY LEAD BURDEN | 9 | 83% | 0% | 5 | Search BODY+LEAD+BURDEN | Search BODY+LEAD+BURDEN |
8 | LEAD BINDING PROTEINS | 9 | 83% | 0% | 5 | Search LEAD+BINDING+PROTEINS | Search LEAD+BINDING+PROTEINS |
9 | PLASMA LEAD | 8 | 70% | 0% | 7 | Search PLASMA+LEAD | Search PLASMA+LEAD |
10 | ALAD | 8 | 36% | 1% | 17 | Search ALAD | Search ALAD |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BONE LEAD | 112 | 53% | 9% | 148 |
2 | SMELTER WORKERS | 66 | 51% | 6% | 92 |
3 | BLOOD LEAD | 51 | 18% | 15% | 248 |
4 | CHELATABLE LEAD | 36 | 79% | 1% | 23 |
5 | ALAD POLYMORPHISM | 35 | 89% | 1% | 16 |
6 | TIBIA LEAD | 31 | 92% | 1% | 12 |
7 | CHRONIC RENAL DISEASES | 30 | 84% | 1% | 16 |
8 | CUMULATIVE LEAD | 21 | 71% | 1% | 17 |
9 | INORGANIC LEAD | 19 | 24% | 4% | 69 |
10 | NEUROBEHAVIORAL TEST SCORES | 19 | 76% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Lead exposure and cardiovascular disease - A systematic review | 2007 | 176 | 80 | 73% |
Mechanisms of lead-induced hypertension and cardiovascular disease | 2008 | 42 | 90 | 76% |
A critical review of biomarkers used for monitoring human exposure to lead: Advantages, limitations, and future needs | 2005 | 178 | 54 | 44% |
Bone lead as a biological marker in epidemiologic studies of chronic toxicity: Conceptual paradigms | 1998 | 186 | 67 | 60% |
The Long-term Consequences of Exposure to Lead | 2009 | 37 | 34 | 76% |
Lead toxicity | 2004 | 85 | 31 | 71% |
Renal effects of environmental and occupational lead exposure | 1997 | 120 | 89 | 80% |
The epidemiology of lead toxicity in adults: Measuring dose and consideration of other methodologic issues | 2007 | 70 | 90 | 66% |
Lead toxicity, a review of the literature. Part 1: Exposure, evaluation, and treatment | 2006 | 144 | 92 | 42% |
Low-dose chronic lead exposure increases systolic arterial pressure and vascular reactivity of rat aortas | 2014 | 2 | 41 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEAD POISONING TRACE ELEMENTS | 7 | 57% | 0.5% | 8 |
2 | IND MED | 4 | 20% | 1.1% | 19 |
3 | CIENCIAS SAUDE VITORIA | 3 | 100% | 0.2% | 3 |
4 | MED PHYS PL RADIAT SCI UNIT | 3 | 22% | 0.7% | 11 |
5 | NORMAT AGING STUDY | 2 | 19% | 0.7% | 11 |
6 | CLIN TOXICOL FOOD SCI ANAL | 2 | 20% | 0.5% | 9 |
7 | INTERNAL MED OCCUPAT DIS HYPERTENS | 2 | 18% | 0.5% | 9 |
8 | NEUROCOGNIT GENET DEV NEUROCOGNIT | 1 | 100% | 0.1% | 2 |
9 | OCCUPAT HLTH PROGRAMLANDMARK | 1 | 100% | 0.1% | 2 |
10 | RCCI | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000247257 | LEAD POISONING//BLOOD LEAD LEVELS//BLOOD LEAD |
2 | 0.0000154448 | LEAD NEUROTOXICITY//PATHOBIOCHEM CENT NERVOUS SYST//BRAIN LEAD |
3 | 0.0000142636 | GENET BREEDING SEED PROD//ANTIOXIDANT AND GENOMIC SYSTEMS//LEAD EXPOSED WORKERS |
4 | 0.0000134354 | MIADMSA//SUCCIMER//MESO 2 3 DIMERCAPTOSUCCINIC ACID DMSA |
5 | 0.0000103520 | URINARY DELTA AMINOLEVULINIC ACID//URINOMETER//URINE SPECIFIC GRAVITY |
6 | 0.0000098971 | HUMAN RIB BONE//TEETH ANALYSIS//ENAMEL BIOPSY |
7 | 0.0000097441 | URINARY CADMIUM//ITAI ITAI DISEASE//MED A2 |
8 | 0.0000094964 | PORPHOBILINOGEN SYNTHASE//5 AMINOLAEVULINIC ACID DEHYDRATASE//MORPHEEIN |
9 | 0.0000086055 | PERINEURIUM//BLOOD NERVE INTERFACE//ENDONEURIAL FLUID |
10 | 0.0000076395 | SENSITIZED ANIMALS//EXPERIMENTAL MICE INFECTION//IMMUNOSENSITIZATION |